XVI European Charcot Foundation lecture: Nutrition and environment, can MS be prevented?

Journal of the Neurological Sciences

Volumn 311, Issue 1-2, 2011, Pages 1-8

  Simon, Kelly Claire ^a,b   Munger, Kassandra L ^a   Ascherio, Alberto ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

EBV; Epidemiology; Multiple sclerosis; Smoking; Vitamin D

Indexed keywords

VITAMIN D;

AUSTRALIA; BODY MASS; CANADA; CASE CONTROL STUDY; DISEASE PREDISPOSITION; ECOLOGY; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; EUROPE; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HYGIENE; INFECTIOUS MONONUCLEOSIS; MULTIPLE SCLEROSIS; NEW ZEALAND; NUTRITION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SMOKING; UNITED STATES; VITAMIN SUPPLEMENTATION;

EID: 81255149361     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.09.009     Document Type: Article

References (137)

1. N. Koch-Henriksen, and K. Hyllested Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry Acta Neurol Scand 78 1988 369 380 (Pubitemid 19002492)
2. M.A. Hernán, M.J. Olek, and A. Ascherio Geographic variation of MS incidence in two prospective studies of US women Neurology 53 1999 1711 1718 (Pubitemid 29530344)
3. S.M. Orton, B.M. Herrera, I.M. Yee, W. Valdar, S.V. Ramagopalan, and A.D. Sadovnick Sex ratio of multiple sclerosis in Canada: a longitudinal study Lancet Neurol 5 2006 932 936 (Pubitemid 44556546)
4. O. Krokki, R. Bloigu, M. Reunanen, and A. Remes Increasing incidence of multiple sclerosis in women in Northern Finland Mult Scler 17 2011 133 138
5. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis. Part I: the role of infection Ann Neurol 61 2007 288 299 (Pubitemid 46676728)
6. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis. Part II: noninfectious factors Ann Neurol 61 2007 504 513 (Pubitemid 47068132)
7. A. Compston, and A. Coles Multiple sclerosis Lancet 359 2002 1221 1231 (Pubitemid 34304266)
8. G.C. Ebers, D.E. Bulman, A.D. Sadovnick, D.W. Paty, S. Warren, and W. Hader A population-based study of multiple sclerosis in twins N Engl J Med 315 1986 1638 1642 (Pubitemid 17052896)
9. T. Hansen, A. Skytthe, E. Stenager, H.C. Petersen, H. Bronnum-Hansen, and K.O. Kyvik Concordance for multiple sclerosis in Danish twins: an update of a nationwide study Mult Scler 11 2005 504 510 (Pubitemid 41387692)
10. D.A. Dyment, G.C. Ebers, and A.D. Sadovnick Genetics of multiple sclerosis Lancet Neurol 3 2004 104 110 (Pubitemid 38121313)
11. International Multiple Sclerosis Genetics Consortium, D.A. Hafler, A. Compston, S. Sawcer, E.S. Lander, and M.J. Daly Risk alleles for multiple sclerosis identified by a genomewide study N Engl J Med 357 2007 851 862 (Pubitemid 47347319)
12. The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Nat Genet 41 2009 824 830
13. The International Multiple Sclerosis Genetics Consortium (IMSGC) Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci Hum Mol Genet 19 2010 953 962
14. P.L. De Jager, X. Jia, J. Wang, P.I. de Bakker, L. Ottoboni, and N.T. Aggarwal Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci Nat Genet 41 2009 776 782
15. S.V. Ramagopalan, and G.C. Ebers Multiple sclerosis: major histocompatibility complexity and antigen presentation Genome Med. 1 2009 105
16. A. Ascherio, and K.L. Munger Epidemiology of multiple sclerosis: environmental factors C.F. Lucchinetti, R. Hohlfeld, Multiple Sclerosis 3 1st ed. 2010 Saunders, Elsevier Philadelphia 57 82
17. J.F. Kurtzke MS epidemiology worldwide. One view of current status Acta Neurol Scand 161 Suppl 1995 23 33
18. B.V. Taylor, R.M. Lucas, K. Dear, T.J. Kilpatrick, M.P. Pender, and I.A. van der Mei Latitudinal variation in incidence and type of first central nervous system demyelinating events Mult Scler 16 2010 398 405
19. C.R. Gale, and C.N. Martyn Migrant studies in multiple sclerosis Prog Neurobiol 47 1995 425 448 (Pubitemid 26022928)
20. M. Elian, and G. Dean Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies J Neurol Neurosurg Psychiatry 50 1987 327 332 (Pubitemid 17025874)
21. M. Elian, S. Nightingale, and G. Dean Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies J Neurol Neurosurg Psychiatry 53 1990 906 911 (Pubitemid 20351059)
22. A. Alonso, and M.A. Hernan Temporal trends in the incidence of multiple sclerosis: a systematic review Neurology 71 2008 129 135
23. M.T. Wallin, W.F. Page, and J.F. Kurtzke Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography Ann Neurol 55 2004 65 71 (Pubitemid 38067362)
24. W.T. Mayr, S.J. Pittock, R.L. McClelland, N.W. Jorgensen, and J.H. Noseworthy Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000 Neurology 61 2003 1373 1377 (Pubitemid 37463373)
25. S.R. Hammond, D.R. English, and J.G. McLeod The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia Brain 123 2000 968 974 (Pubitemid 30224192)
26. C.J. Willer, D.A. Dyment, A.D. Sadovnick, P.M. Rothwell, T.J. Murray, and G.C. Ebers Timing of birth and risk of multiple sclerosis: population based study BMJ 330 2005 120
27. J. Salzer, A. Svenningsson, and P. Sundstrom Season of birth and multiple sclerosis in Sweden Acta Neurol Scand 121 2010 20 23
28. J. Staples, A.L. Ponsonby, and L. Lim Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis BMJ 2010 340 10.1136/bmj.c1640
29. M.A. Hernán, M.J. Olek, and A. Ascherio Cigarette smoking and incidence of multiple sclerosis Am J Epidemiol 154 2001 69 74 (Pubitemid 32565688)
30. A.K. Hedstrom, M. Baarnhielm, T. Olsson, and L. Alfredsson Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis Neurology 73 2009 696 701
31. T. Riise, M.W. Nortvedt, and A. Ascherio Smoking is a risk factor for multiple sclerosis Neurology 61 2003 1122 1124 (Pubitemid 37461949)
32. E.G. Celius, and C. Smestad Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades Acta Neurol Scand 2009 27 29 Suppl.
33. S.M. Orton, S.V. Ramagopalan, D.M. Brocklebank, B.M. Herrera, D.A. Dyment, and I.M. Yee Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study J Neurol Neurosurg Psychiatry 81 2010 31 36
34. N. Palacios, A. Alonso, H. Bronnum-Hansen, and A. Ascherio Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence Ann Epidemiol 21 2011 536 542
35. D.C. Poskanzer, A.M. Walker, J. Yonkondy, and J.L. Sheridan Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands Neurology Part 2 1976 14 17
36. J.F. Bach The effect of infections on susceptibility to autoimmune and allergic diseases N Engl J Med 347 2002 911 920
37. D.A. Hafler The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis [comment] J Clin Invest 104 1999 527 529
38. S.F. Hunter, and D.A. Hafler Ubiquitous pathogens: links between infection and autoimmunity in MS? [editorial; comment] Neurology 55 2000 164 165 (Pubitemid 30604611)
39. U. Leibowitz, A. Antonovsky, J.M. Medalie, H.A. Smith, L. Halpern, and M. Alter Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation J Neurol Neurosurg Psychiatry 29 1966 60 68
40. G.W. Beebe, J.F. Kurtzke, L.T. Kurland, T.L. Auth, and B. Nagler Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the Army experience in World War II Neurology 17 1967 1 17
41. J.F. Kurtzke, and W.F. Page Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS Neurology 48 1997 204 213 (Pubitemid 27039542)
42. W.R. Russell Multiple sclerosis: occupation and social group at onset Lancet 2 1971 832 834
43. E.L. Thacker, F. Mirzaei, and A. Ascherio Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis Ann Neurol 59 2006 499 503 (Pubitemid 43358070)
44. A.E. Handel, A.J. Williamson, G. Disanto, L. Handunnetthi, G. Giovannoni, and S.V. Ramagopalan An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis PLoS One 5 9 2010 pii: e12496
45. J.C. Niederman, and A.S. Evans Epstein-Barr Virus A.S. Evans, R.A. Kaslow, Viral infections of humans: epidemiology and control Fourth ed. 1997 Plenum Medical Book Company New York 253 283
46. T.J. Hallee, A.S. Evans, J.C. Niederman, C.M. Brooks, and J.H. Voegtly Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years Yale J Biol Med 3 1974 182 195
47. A.B. Rickinson, and E. Kieff Epstein-Barr virus B.N. Fields, D.M. Knipe, P.M. Howley, Fields virology Third ed. 1996 Lippincott-Raven Publishers Philadelphia 2397 2446
48. H.B. Warner, and R.I. Carp Multiple sclerosis and Epstein-Barr virus (letter) Lancet 2 1981 1290
49. H.B. Warner, and R.I. Carp Multiple sclerosis etiology - an Epstein-Barrr virus hypothesis Med Hypotheses 25 1988 93 97 (Pubitemid 18041231)
50. L.I. Levin, K.L. Munger, E.J. O'Reilly, K.I. Falk, and A. Ascherio Primary infection with the Epstein-Barr virus and risk of multiple sclerosis Ann Neurol 67 2010 824 830
51. L.I. Levin, K.L. Munger, M.V. Rubertone, C.A. Peck, E.T. Lennette, and D. Spiegelman Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis JAMA 293 2005 2496 2500 (Pubitemid 40705731)
52. G.N. DeLorenze, K.L. Munger, E. Lennette, N. Orentreich, J. Vogelman, and A. Ascherio Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up Arch Neurol 63 2006 839 844 (Pubitemid 43882291)
53. A. Ascherio, K.L. Munger, E.T. Lennette, D. Spiegelman, M.A. Hernán, and M.J. Olek Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study JAMA 286 2001 3083 3088 (Pubitemid 34016522)
54. P. Sundstrom, P. Juto, G. Wadell, G. Hallmans, A. Svenningsson, and L. Nystrom An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study Neurology 62 2004 2277 2282 (Pubitemid 38787787)
55. K.L. Munger, L.I. Levin, E.J. O'Reilly, K.I. Falk, and A. Ascherio Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel Mult Scler 17 10 2011 1185 1193
56. P.L. De Jager, K.C. Simon, K.L. Munger, J.D. Rioux, D.A. Hafler, and A. Ascherio Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis Neurology 70 2008 1113 1118 (Pubitemid 351464768)
57. P. Sundstrom, L. Nystrom, E. Jidell, and G. Hallmans EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study Mult Scler 14 2008 1120 1122
58. K.C. Simon, I.A. Van der Mei, K.L. Munger, A.L. Ponsonby, J.L. Dickinson, and T. Dwyer Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk Neurology 74 2010 1365 1371
59. J.F. Kurtzke, and A. Heltberg Multiple sclerosis in the Faroe Islands: an epitome J Clin Epidemiol 54 2001 1 22 (Pubitemid 32106971)
60. M. Abdel-Hamid, J.J. Chen, N. Constantine, M. Massoud, and N. Raab-Traub EBV strain variation: geographical distribution and relation to disease state Virology 190 1992 168 175
61. L.S. Young, Q.Y. Yao, C.M. Rooney, T.B. Sculley, D.J. Moss, and H. Rupani New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas J Gen Virol 68 Pt 11 1987 2853 2862
62. I. Ernberg, B. Kallin, J. Dillner, K. Falk, B. Ehlin-Henriksson, and M.L. Hammarskjold Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen Int J Cancer 38 1986 729 737 (Pubitemid 17189133)
63. U. Zimber, H.K. Adldinger, G.M. Lenoir, M. Vuillaume, M.V. Knebel-Doeberitz, and G. Laux Geographical prevalence of two types of Epstein-Barr virus Virology 154 1986 56 66 (Pubitemid 16015594)
64. R. Brennan, J. Burrows, M. Bell, L. Bromham, P. Csurhes, and A. Lenarczyk Strains of Epstein-Barr virus infecting multiple sclerosis patients Mult Scler 16 2010 643 651
65. K.C. Simon, X. Yang, K.L. Munger, and A. Ascherio EBNA1 and LMP1 variants in multiple sclerosis cases and controls Acta Neurol Scand 124 2010 53 58
66. J.W. Lindsey, S. Patel, and J. Zou Epstein-Barr virus genotypes in multiple sclerosis Acta Neurol Scand 117 2008 141 144
67. M. Munch, J. Hvas, T. Christensen, A. Møller-Larsen, and S. Haahr A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters Acta Neurol Scand 98 1998 395 399 (Pubitemid 29003133)
68. A. Ascherio, K.L. Munger, and K.C. Simon Vitamin D and multiple sclerosis Lancet Neurol 9 2010 599 612
69. I.A. van der Mei, A.L. Ponsonby, L. Blizzard, and T. Dwyer Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation Neuroepidemiology 20 2001 168 174 (Pubitemid 32718873)
70. E.D. Acheson, C.A. Bachrach, and F.M. Wright Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables Acta Psychiatr Scand 147 1960 132 147
71. B.D. Beretich, and T.M. Beretich Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis Mult Scler 15 2009 891 898
72. A.L. Ponsonby, R.M. Lucas, and I.A. van der Mei UVR, vitamin D and three autoimmune diseases - multiple sclerosis, type 1 diabetes, rheumatoid arthritis Photochem Photobiol 81 2005 1267 1275 (Pubitemid 43035835)
73. M.F. Holick Environmental factors that influence the cutaneous production of vitamin D Am J Clin Nutr 61 suppl 1995 638S 645S
74. M.F. Holick Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease Am J Clin Nutr 80 2004 1678S 1688S
75. E.B. Mawer, G.A. Lumb, and S.W. Stanbury Long biological half-life of vitamin D3 and its polar metabolites in human serum Nature 222 1969 482 483
76. J.E. Smith, and D.S. Goodman The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma J Clin Invest 50 1971 2159 2167
77. C.E. Hayes, F.E. Nashold, K.M. Spach, and L.B. Pedersen The immunological functions of the vitamin D endocrine system Cell Mol Biol 49 2003 277 300
78. J.M. Lemire, and D.C. Archer 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J Clin Invest 87 1991 1103 1107
79. D.D. Branisteanu, M. Waer, H. Sobis, S. Marcelis, M. Vandeputte, and R. Bouillon Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3 J Neuroimmunol 61 1995 151 160
80. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proc Natl Acad Sci U S A 93 1996 7861 7864 (Pubitemid 26277129)
81. K.M. Spach, F.E. Nashold, B.N. Dittel, and C.E. Hayes IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis J Immunol 177 2006 6030 6037 (Pubitemid 44628817)
82. S. Nataf, E. Garcion, F. Darcy, D. Chabannes, J.Y. Muller, and P. Brachet 1, 25 dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis J Neuropathol Exp Neurol 55 1996 904 914 (Pubitemid 26287007)
83. F.E. Nashold, D.J. Miller, and C.E. Hayes 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis J Neuroimmunol 103 2000 171 179 (Pubitemid 30079729)
84. F.E. Nashold, K.A. Hoag, J. Goverman, and C.E. Hayes Rag-1 -dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis J Neuroimmunol 119 2001 16 29 (Pubitemid 32781724)
85. K.M. Spach, and C.E. Hayes Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice J Immunol 175 2005 4119 4126 (Pubitemid 41292076)
86. F.E. Nashold, K.M. Spach, J.A. Spanier, and C.E. Hayes Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression J Immunol 183 2009 3672 3681
87. P. Goldberg Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint) part 1: sunlight, dietary factors and epidemiology Int J Environ Stud 6 1974 19 27
88. R.L. Swank, O. Lerstad, A. Strøm, and J. Backer Multiple sclerosis in rural Norway. Its geographic and occupational incidence in relation to nutrition N Engl J Med 246 1952 721 728
89. K. Westlund Distribution and mortality time trend of multiple sclerosis and some other diseases in Norway Acta Neurol Scand 46 1970 455 483
90. D.M. Freedman, M. Dosemeci, and M.C. Alavanja Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates Occup Environ Med 57 2000 418 421 (Pubitemid 30312755)
91. M. Westberg, M. Feychting, F. Jonsson, G. Nise, and P. Gustavsson Occupational exposure to UV light and mortality from multiple sclerosis Am J Ind Med 52 2009 353 357
92. M.J. Goldacre, V. Seagroatt, D. Yeates, and E.D. Acheson Skin cancer in people with multiple sclerosis: a record linkage study J Epidemiol Community Health 58 2004 142 144 (Pubitemid 38130483)
93. R. Midgard, E. Glattre, M. Gronning, T. Riise, A. Edland, and H. Nyland Multiple sclerosis and cancer in Norway. A retrospective cohort study Acta Neurol Scand 93 1996 411 415 (Pubitemid 26232751)
94. N.M. Nielsen, K. Rostgaard, S. Rasmussen, N. Koch-Henriksen, H.H. Storm, and M. Melbye Cancer risk among patients with multiple sclerosis: a population-based register study Int J Cancer 118 2006 979 984 (Pubitemid 43157674)
95. C. Lebrun, M. Debouverie, P. Vermersch, P. Clavelou, L. Rumbach, and J. de Seze Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis Mult Scler 14 2008 399 405 (Pubitemid 351676435)
96. S. Bahmanyar, S.M. Montgomery, J. Hillert, A. Ekbom, and T. Olsson Cancer risk among patients with multiple sclerosis and their parents Neurology 72 2009 1170 1177
97. W. Cendrowski, M. Wender, W. Dominik, Z. Flejsierowicz, M. Owsianowski, and M. Popiel Epidemiological study of multiple sclerosis in Western Poland Eur Neurol 2 1969 90 108
98. I.A.F. van der Mei, A.L. Ponsonby, T. Dwyer, L. Blizzard, R. Simmons, and B.V. Taylor Past exposure to sun, skin phenotype and risk of multiple sclerosis: a case-control study BMJ 327 2003 316 321
99. M.T. Kampman, T. Wilsgaard, and S.I. Mellgren Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle J Neurol 254 2007 471 477 (Pubitemid 46786722)
100. A. Antonovsky, U. Leibowitz, H.A. Smith, J.M. Medalie, M. Balogh, and R. Kats Epidemiologic study of multiple sclerosis in Israel Arch Neurol 13 1965 183 193
101. P. Ghadirian, M. Jain, S. Ducic, B. Shatenstein, and R. Morisset Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada Int J Epidemiol 27 1998 845 852 (Pubitemid 28504973)
102. K.L. Munger, T. Chitnis, A.L. Frazier, E. Giovannucci, D. Spiegelman, and A. Ascherio Dietary intake of vitamin D during adolescence and risk of multiple sclerosis J Neurol 258 2011 479 485
103. E. Giovannucci, M.J. Stampfer, G.A. Colditz, J.E. Manson, B.A. Rosner, and M. Longnecker A comparison of prospective and retrospective assessments of diet in the study of breast cancer Am J Epidemiol 137 1993 502 511 (Pubitemid 23109751)
104. K.L. Munger, S.M. Zhang, E. O'Reilly, M.A. Hernán, M.J. Olek, and W.C. Willett Vitamin D intake and incidence of multiple sclerosis Neurology 62 2004 60 65 (Pubitemid 38082871)
105. F. Mirzaei, K.B. Michels, K. Munger, E. O'Reilly, T. Chitnis, and M.R. Forman Gestational vitamin D and the risk of multiple sclerosis in offspring Ann Neurol 70 2011 30 40
106. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2006 2832 2838 (Pubitemid 44969183)
107. B.W. Hollis Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D J Nutr 135 2005 317 322 (Pubitemid 40194499)
108. B. Dawson-Hughes, R.P. Heaney, M.F. Holick, P. Lips, P.J. Meunier, and R. Vieth Estimates of optimal vitamin D status Osteoporos Int 16 2005 713 716 (Pubitemid 40933586)
109. R. Vieth, and D. Vitamin Supplementation, 25-hydroxyvitamin D concentrations and safety Am J Clin Nutr 69 1999 842 856
110. R.P. Heaney Long-latency deficiency disease: insights from calcium and vitamin D Am J Clin Nutr 78 2003 912 919 (Pubitemid 40003750)
111. A.C. Looker, C.M. Pfeiffer, D.A. Lacher, R.L. Schleicher, M.F. Picciano, and E.A. Yetley Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004 Am J Clin Nutr 88 2008 1519 1527
112. E. Hypponen, and C. Power Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors Am J Clin Nutr 85 2007 860 868 (Pubitemid 46393520)
113. S.V. Ramagopalan, N.J. Maugeri, L. Handunnetthi, M.R. Lincoln, S. Orton, and D.A. Dyment Expression of the multiple sclerosis-associated MHC class II allele HLA-DrB1*1501 is regulated by vitamin D PLoS Genet 5 2009 e1000369
114. S.V. Ramagopalan, A. Heger, A.J. Berlanga, N.J. Maugeri, M.R. Lincoln, and A. Burrell A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution Genome Res 20 2010 1352 1360
115. J.E. Compston, S. Vedi, J.E. Ledger, A. Webb, J.C. Gazet, and T.R. Pilkington Vitamin D status and bone histomorphometry in gross obesity Am J Clin Nutr 34 1981 2359 2363 (Pubitemid 12176062)
116. H. Hey, K.H. Stokholm, B. Lund, B. Lund, and O.H. Sorensen Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass Int J Obes 6 1982 473 479 (Pubitemid 12000152)
117. N.H. Bell, S. Epstein, A. Greene, J. Shary, M.J. Oexmann, and S. Shaw Evidence for alteration of the vitamin D-endocrine system in obese subjects J Clin Invest 76 1985 370 373 (Pubitemid 15243466)
118. Y. Liel, E. Ulmer, J. Shary, B.W. Hollis, and N.H. Bell Low circulating vitamin D in obesity Calcif Tissue Int 43 1988 199 201
119. J. Wortsman, L.Y. Matsuoka, T.C. Chen, Z. Lu, and M.F. Holick Decreased bioavailability of vitamin D in obesity Am J Clin Nutr 72 2000 690 693 (Pubitemid 30667088)
120. S.J. Parikh, M. Edelman, G.I. Uwaifo, R.J. Freedman, M. Semega-Janneh, and J. Reynolds The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults J Clin Endocrinol Metab 89 2004 1196 1199 (Pubitemid 38368412)
121. G. Matarese, P.B. Carrieri, A. La Cava, F. Perna, V. Sanna, and V. De Rosa Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells Proc Natl Acad Sci USA 102 2005 5150 5155
122. G. Matarese, A. Di Giacomo, V. Sanna, G.M. Lord, J.K. Howard, and A. Di Tuoro Requirement for leptin in the induction and progression of autoimmune encephalomyelitis J Immunol 166 2001 5909 5916 (Pubitemid 32440714)
123. G. Matarese, V. Sanna, A. Di Giacomo, G.M. Lord, J.K. Howard, and S.R. Bloom Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males Eur J Immunol 31 2001 1324 1332 (Pubitemid 32454681)
124. K.L. Munger, T. Chitnis, and A. Ascherio Body size and risk of MS in two cohorts of US women Neurology 73 2009 1543 1550
125. P. Sundstrom, M. Nystrom, K. Ruuth, and E. Lundgren Antibodies to specific EBNA-1 domains and HLA DRB11501 interact as risk factors for multiple sclerosis J Neuroimmunol 215 2009 102 107
126. T. Nielsen, K. Rostgaard, J. Askling, R. Steffensen, A. Oturai, and C. Jersild Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis Mult Scler 15 2009 431 436
127. S.V. Ramagopalan, A.D. Sadovnick, G.C. Ebers, and G. Giovannoni Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis Mult Scler 16 2010 127 128
128. S.V. Ramagopalan, J. Link, J.K. Byrnes, D.A. Dyment, G. Giovannoni, and R.Q. Hintzen HLA-DRB1 and month of birth in multiple sclerosis Neurology 73 2009 2107 2111
129. S.V. Ramagopalan, D.A. Dyment, G. Giovannoni, A.D. Sadovnick, and G.C. Ebers HLA-DRB1*15, low infant sibling exposure, and multiple sclerosis gene-environment interaction Ann Neurol 67 2010 694 695
130. J. Dickinson, D. Perera, A. van der Mei, A.L. Ponsonby, A. Polanowski, and R. Thomson Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction Mult Scler 15 2009 563 570
131. T. Dwyer, I. van der Mei, A.L. Ponsonby, B.V. Taylor, J. Stankovich, and J.D. McKay Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis Neurology 71 2008 583 589
132. K.C. Simon, K.L. Munger, X. Yang, and A. Ascherio Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis Mult Scler 16 2010 133 138
133. E. Sundqvist, P. Sundstrom, M. Linden, A.K. Hedstrom, F. Aloisi, and J. Hillert Epstein-Barr virus and multiple sclerosis: interaction with HLA Genes Immun Jul 21 2011 10.1038/gene.2011.42 [Epub ahead of print]
134. A.K. Hedstrom, E. Sundqvist, M. Baarnhielm, N. Nordin, J. Hillert, and I. Kockum Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis Brain 134 2011 653 664
135. R.M. Lucas, A.L. Ponsonby, K. Dear, P. Valery, M.P. Pender, and J.M. Burrows Current and past Epstein-Barr virus infection in risk of initial CNS demyelination Neurology 77 2011 371 379
136. B. McMahon, and T.F. Pugh Causes and entities of disease Prev Med 1 1967 11 18
137. I.A. van der Mei, A.L. Ponsonby, B.V. Taylor, J. Stankovich, J.L. Dickinson, S. Foote, A. Kemp, and T. Dwyer Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: gene-environment interaction Ann Neurol 67 2 2010 261 265